[EN] MACROCYLIC PYRIMIDINE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRIMIDINE MACROCYCLIQUES
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2015150555A1
公开(公告)日:2015-10-08
The present invention relates to substituted macrocylic pyrimidine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention have EF2K inhibitory activity and optionally also Vps34 inhibitory activity. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
The invention relates to new quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by a partly hydrogenated isoindolinyl ring, processes for their preparation and antibacterial agents and feed additives containing these compounds.
A simple and industrially viable protocol for C–N and C–O coupling was reported here. The polymer supported heterogeneous copper catalyst was prepared from chloromethyl polystyrene using a simple procedure. O-Arylation of substitutedphenols with various arylhalides was achieved using this copper catalyst in DMSO medium. This heterogeneous copper catalyst, also efficiently works for the N-arylation
Process for the preparation of dimethoxyanthraquinones
申请人:Bayer Aktiengesellschaft
公开号:US04278607A1
公开(公告)日:1981-07-14
Dimethoxyanthraquinones can be prepared in high purity and in good yield in an economic manner which does not pollute the environment when 1 part by weight of dinitroanthraquinone is reacted with 2-8 parts by weight of methanol and 0.5-1.5 parts by weight of potassium hydroxide until all of the nitro groups have been replaced; the reaction is preferably carried out in the presence of 0.05-0.5 part by weight of amidosulphonic acid.